Low prevalence of HPV detection and genotyping in non-muscle invasive bladder cancer using single-step PCR followed by reverse line blot

[1]  K. Cuschieri,et al.  An evaluation of the Qiagen HPV sign for the detection and genotyping of cervical lesions and oropharyngeal squamous cell carcinomas. , 2014, Journal of virological methods.

[2]  J. Casalegno,et al.  p16INK4a overexpression is not linked to oncogenic human papillomaviruses in patients with high‐grade urothelial cancer cells , 2014, Cancer cytopathology.

[3]  M. Chiriva-Internati,et al.  The Role of Human Papilloma Virus (HPV) Infection in Non-Anogenital Cancer and the Promise of Immunotherapy: A Review , 2014, International reviews of immunology.

[4]  C. Meijer,et al.  Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions , 2014, Nature Reviews Cancer.

[5]  R. Montironi,et al.  The Expression Patterns of p53 and p16 and an Analysis of a Possible Role of HPV in Primary Adenocarcinoma of the Urinary Bladder , 2014, PloS one.

[6]  W. Park,et al.  Detection of Human Papillomavirus Infection and p16 Immunohistochemistry Expression in Bladder Cancer with Squamous Differentiation , 2014, PloS one.

[7]  F. Mege-Lechevallier,et al.  p16INK4a overexpression and p16/Ki‐67 dual labeling versus conventional urinary cytology in the evaluation of urothelial carcinoma , 2014, Cancer cytopathology.

[8]  B. Hadaschik,et al.  Human papillomaviruses in urological malignancies: a critical assessment. , 2014, Urologic oncology.

[9]  H. Klocker,et al.  Is real-time PCR the correct method to evaluate the incidence of human papillomavirus in prepuces of asymptomatic boys and men? , 2014, World Journal of Urology.

[10]  S. Rosini,et al.  Chromogenic In Situ Hybridization and p16/Ki67 Dual Staining on Formalin-Fixed Paraffin-Embedded Cervical Specimens: Correlation with HPV-DNA Test, E6/E7 mRNA Test, and Potential Clinical Applications , 2013, BioMed research international.

[11]  M. Cronauer,et al.  Overexpression of p16INK4a in Urothelial Carcinoma In Situ Is a Marker for MAPK-Mediated Epithelial-Mesenchymal Transition but Is Not Related to Human Papillomavirus Infection , 2013, PloS one.

[12]  T. Longacre,et al.  Laboratory-developed L1 sequencing and type-specific, real-time polymerase chain reaction for the detection and typing of human papillomaviruses in formalin-fixed, paraffin-embedded tissues. , 2013, Archives of pathology & laboratory medicine.

[13]  W. Horninger,et al.  Prevalence of the human papillomavirus (HPV) expression of the inner prepuce in asymptomatic boys and men , 2013, World Journal of Urology.

[14]  D. Spandidos,et al.  Association of human herpes, papilloma and polyoma virus families with bladder cancer , 2013, Tumor Biology.

[15]  A. Lopez‐Beltran,et al.  p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma , 2012, Modern Pathology.

[16]  H. Baloglu,et al.  Role of human papillomavirus in the development of urothelial carcinoma , 2011, Medical oncology.

[17]  Ni Li,et al.  Human papillomavirus infection and bladder cancer risk: a meta-analysis. , 2011, The Journal of infectious diseases.

[18]  T. Sasagawa,et al.  Etiologic role of human papillomavirus infection in bladder carcinoma , 2011, Cancer.

[19]  D. Broer,et al.  Rapid Genotyping of Human Papillomavirus by Post-PCR Array-Based Hybridization Techniques , 2011, Journal of Clinical Microbiology.

[20]  M. Schmitt,et al.  Human papillomavirus and p16 expression in inverted papillomas of the urinary bladder. , 2010, Cancer letters.

[21]  P. Conesa‐Zamora,et al.  Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, Cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study. , 2009, American journal of clinical pathology.

[22]  A. Tzankov,et al.  Large-Scale Analysis of Cell Cycle Regulators in Urothelial Bladder Cancer Identifies p16 and p27 as Potentially Useful Prognostic Markers , 2008, Pathobiology.

[23]  Lawrence J. Faucette,et al.  Immunohistochemistry and In Situ Hybridization , 2006 .

[24]  C. Proby,et al.  Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis , 2005, Journal of Clinical Pathology.

[25]  A. Staudach,et al.  Comparison of Real-Time PCR Signal-Amplified In Situ Hybridization and Conventional PCR for Detection and Quantification of Human Papillomavirus in Archival Cervical Cancer Tissue , 2004, Journal of Clinical Microbiology.

[26]  M. Knowles.  Human papillomavirus sequences are not detectable by Southern blotting or general primer-mediated polymerase chain reaction in transitional cell tumours of the bladder , 2004, Urological Research.

[27]  R. A. Hubbard,et al.  Human papillomavirus testing methods. , 2009, Archives of pathology & laboratory medicine.

[28]  A. Zekri,et al.  Correlation between p53 mutations and HPV in bilharzial bladder cancer. , 2003, Urologic oncology.

[29]  E. Laconi,et al.  One-step detection and genotyping of human papillomavirus in cervical samples by reverse hybridization. , 2001, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[30]  S. Bettelli,et al.  Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridisation. , 1999, Journal of clinical pathology.

[31]  P. Abel,et al.  Human papillomavirus 16 and 18 infection is absent in urinary bladder carcinomas. , 1998, European urology.

[32]  H. Hollema,et al.  Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas , 1996, Journal of clinical microbiology.

[33]  L. Vicioso,et al.  Human papillomavirus DNA as a factor determining the survival of bladder cancer patients. , 1996, British Journal of Cancer.

[34]  A. López-Beltran,et al.  Human papillomavirus infection and transitional cell carcinoma of the bladder. Immunohistochemistry and in situ hybridization. , 1996, Pathology, research and practice.

[35]  B. Johansson,et al.  Modifications of human and viral deoxyribonucleic acid by formaldehyde fixation. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[36]  R. Cote,et al.  Two molecular pathways to transitional cell carcinoma of the bladder. , 1994, Cancer research.

[37]  T. Wright,et al.  Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. , 1992, Molecular and cellular probes.